| 1 |
29618584 | Leflunomide Increases Hepatic Exposure to Methotrexate and Its Metabolite by Differentially Regulating Multidrug Resistance-Associated Protein Mrp2/3/4 Transporters via Peroxisome Proliferator-Activated Receptor α Activation. | 2018 Jun |
1 |
| 2 |
21566011 | Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate. | 2011 Aug |
3 |
| 3 |
21841039 | Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models. | 2011 Nov |
1 |
| 4 |
19383815 | Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo. | 2009 May 1 |
4 |
| 5 |
19996279 | Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo. | 2009 Dec |
4 |
| 6 |
19088030 | Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate. | 2008 Dec 15 |
8 |
| 7 |
15313923 | Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. | 2004 Aug 15 |
1 |